Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life

Erythrodermic mycosis fungoides and Sézary syndrome are chronic, relapsing‐remitting diseases that greatly impacts patients' quality of life (QoL). Mogamulizumab‐kpkc (Mogamulizumab) is a novel therapeutic agent for cutaneous T‐cell lymphomas with a notable impact on progression‐free survival....

Descripción completa

Detalles Bibliográficos
Autores principales: Ottevanger, Rosanne, Feenstra, Judith S., van Vliet, Liesbeth M., van Beugen, Sylvia, Evers, Andrea W. M., Kennedy, Cees, Willemze, Rein, Vermeer, Maarten H., Quint, Koen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690699/
https://www.ncbi.nlm.nih.gov/pubmed/38047257
http://dx.doi.org/10.1002/ski2.300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690699/
https://www.ncbi.nlm.nih.gov/pubmed/38047257
http://dx.doi.org/10.1002/ski2.300

Ejemplares similares